Ajanta Pharmaceuticals Balance Sheet Annual

Trade

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs

3,001.80 +41.50 (1.40%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	129.49	329.83	206.37	177.51
Cash Equivalents	1.28	-	-	-
Short Term Investments	349.07	510.27	121.86	200.67
Cashand Short Term Investments	479.84	840.10	328.23	378.18
Accounts Receivable- Trade Net	1,246.84	1,059.38	1,020.39	740.19
Total Receivables Net	1,280.80	1,125.06	1,082.54	835.83
Total Inventory	828.36	842.51	815.58	788.55
Other Current Assets Total	133.07	1.07	22.53	11.19
Total Current Assets	2,722.07	2,825.18	2,264.46	2,027.59
Property/ Plant/ Equipment Total- Net	1,720.98	1,698.16	1,647.42	1,629.61
Intangibles Net	14.66	7.75	9.02	10.79
Long Term Investments	27.94	25.10	33.51	8.90
Note Receivable- Long Term	0.00	6.26	33.68	42.06
Other Long Term Assets Total	152.74	116.57	67.49	59.77
Total Assets	4,638.39	4,679.02	4,055.58	3,778.72
Accounts Payable	463.20	422.77	327.17	373.86
Current Portof LT Debt/ Capital Leases	11.76	9.43	6.46	11.59
Other Currentliabilities Total	420.29	707.08	313.76	263.18
Total Current Liabilities	895.25	1,139.28	647.39	648.63
Capital Lease Obligations	23.52	26.20	18.57	19.77
Total Long Term Debt	23.52	26.20	18.57	19.77
Total Debt	35.28	35.63	25.03	31.36
Deferred Income Tax	108.50	97.72	101.87	92.17
Other Liabilities Total	43.76	27.83	23.41	22.52
Total Liabilities	1,071.03	1,291.03	791.24	783.09
Common Stock Total	25.27	25.27	17.17	17.39
Retained Earnings( Accumulated Deficit)	3,542.09	3,352.75	3,252.10	2,974.96
Total Equity	3,567.36	3,387.99	3,264.34	2,995.63
Total Liabilities Shareholders' Equity	4,638.39	4,679.02	4,055.58	3,778.72
Total Common Shares Outstanding	12.59	12.59	12.93	12.98
Tangible Book Valueper Share Common Eq	282.15	268.45	251.82	229.96
Prepaid Expenses	-	16.44	15.58	13.84
Property/ Plant/ Equipment Total- Gross	-	2,250.94	2,177.98	2,103.17
Accumulated Depreciation Total	-	-762.25	-683.42	-581.75
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
Additional Paid- In Capital	-	0.00	0.00	0.00
ESOP Debt Guarantee	-	0.34	0.30	0.54
Other Equity Total	-	9.63	-5.23	2.74